PDS Biotechnology Corporation
NASDAQ:PDSB · NASDAQ Capital Market
+$0.01 today
Vol 0.42M · Avg 1.04M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-37.99%
Period High
$1.60
Period Low
$0.54
Latest
$0.96
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Xilio Therapeutics, Inc.
NASDAQ:XLO
$61.12M
OnKure Therapeutics, Inc.
NASDAQ:OKUR
$58.45M
Kezar Life Sciences, Inc.
KZR
$53.86M
LAVA Therapeutics N.V.
LVTX
$45.77M
FibroGen, Inc.
FGEN
$36.69M
INmune Bio, Inc.
INMB
$36.55M
Annovis Bio, Inc.
ANVS
$34.92M
Actinium Pharmaceuticals, Inc.
ATNM
$32.21M
Tempest Therapeutics, Inc.
TPST
$5.49M
Reviva Pharmaceuticals Holdings, Inc.
RVPH
$2.05M
What is the latest PDSB filing?
The latest filing shown is 8-K dated Jun 15, 2026.
How many recent filings does PDSB have?
Intrinsic Alpha currently shows 20 recent filings for PDSB.
Explore More
Continue the stock analysis
Jump to another research area for this company.